Silver Book Fact

A statin initiation intervention aimed at Medicare Part D prescription drug plan subscribers with diabetes or coronary artery disease was successful in increasing statin use among this group of members at high risk for cardiovascular events. The estimated coronary event cost avoidance was $12,323 per 220 members who received the intervention.

Stockl K, Tjioe D, Gong S, et al. Effect of an Intervention to Increase Statin Use in Medicare Members Who Qualified for a Medication Therapy Management Program. J Manag Care Pharm. 2008; 14(6): 532-40. https://pubmed.ncbi.nlm.nih.gov/18693777/

Reference

Title
Effect of an Intervention to Increase Statin Use in Medicare Members Who Qualified for a Medication Therapy Management Program
Publication
J Manag Care Pharm
Publication Date
2008
Authors
Stockl K, Tjioe D, Gong S, et al
Volume & Issue
Volume 14, Issue 6
Pages
532-40
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Economics of DR Treatment
    Laser treatment plus a VEGF inhibitor achieved an incremental cost-effectiveness ratio of $12,410 per quality adjusted life year in patients with DME.  
  • The risk of developing eye, kidney and nerve disease is reduced by 40% for every 1% reduction in blood glucose levels.  
  • Widespread use of diabetes prevention drugs that enhance insulin sensitivity could result in a 50% prevention of type 2 diabetes over a 10 to 15 year period.  
  • Intensive Glycemic Control in People with Diabetes
    Intensive glycemic control in diabetics reduced their: Adjusted mean risk of DR by 76% Risk of progression by 54% Rates of laser surgery by 56% Risk of DME by 23%    
  • Blood pressure control reduces the risk of cardiovascular disease (heart disease or stroke) among people with diabetes by 33% to 50%, and the risk of microvascular complications (eye, kidney, and…